Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Pacific Health Care OrganizationCaladrius BiosciencesCurative BiotechnologyEmmaus Life SciencesCryo-Cell International
SymbolOTCMKTS:PFHODNASDAQ:CLBSOTCMKTS:CTYXOTCMKTS:EMMAOTCMKTS:CCEL
Price Information
Current Price$1.25$1.53$0.12$1.30$9.88
52 Week RangeN/ABuyN/AN/AN/A
MarketRank™
Overall Score0.51.50.00.20.9
Analysis Score0.03.40.00.00.0
Community Score1.72.70.00.02.3
Dividend Score0.00.00.00.00.0
Ownership Score0.80.00.00.81.7
Earnings & Valuation Score0.01.30.00.00.6
Analyst Ratings
Consensus RecommendationN/ABuyN/AN/AN/A
Consensus Price TargetN/A$10.00N/AN/AN/A
% Upside from Price TargetN/A553.59% upsideN/AN/AN/A
Trade Information
Market Cap$52.48 million$91.03 million$47.20 million$63.68 million$74.80 million
Beta0.941.55-31.942.340.29
Average Volume1,7205,843,2323,043,44314,4558,474
Sales & Book Value
Annual Revenue$6.80 millionN/AN/A$1.32 million$31.80 million
Price / Sales2.35N/AN/A48.242.35
Cashflow$0.11 per shareN/AN/AN/A$0.46 per share
Price / Cash11.21N/AN/AN/A21.68
Book Value$0.63 per share$1.98 per shareN/AN/A($0.89) per share
Price / Book1.98N/AN/A-11.10
Profitability
Net Income$1.36 million$-19,360,000.00N/A$-2,370,000.00$2.29 million
EPSN/A($1.88)N/AN/AN/A
Trailing P/E Ratio0.00N/A0.000.0024.70
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins16.87%N/AN/AN/A10.39%
Return on Equity (ROE)14.47%-68.33%N/AN/A-58.74%
Return on Assets (ROA)12.96%-57.61%N/AN/A7.30%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%N/AN/AN/AN/A
Current Ratio12.91%9.87%N/AN/A1.16%
Quick Ratio12.91%9.87%N/AN/A1.08%
Ownership Information
Institutional Ownership PercentageN/A8.99%N/A0.12%0.98%
Insider Ownership Percentage61.60%10.30%N/A36.88%53.80%
Miscellaneous
Employees3924N/A2889
Shares Outstanding12.80 million59.50 million388.50 million48.99 million7.57 million
Next Earnings DateN/A5/6/2021 (Estimated)6/8/2021 (Estimated)N/A7/9/2021 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke UniversityCord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University
finance.yahoo.com - April 12 at 12:31 PM
Cryo-Cell International (OTCMKTS:CCEL) Stock Passes Above Fifty Day Moving Average of $9.16Cryo-Cell International (OTCMKTS:CCEL) Stock Passes Above Fifty Day Moving Average of $9.16
americanbankingnews.com - April 6 at 2:38 AM
Cryo-Cell International, Inc. (OTCMKTS:CCEL) Short Interest UpdateCryo-Cell International, Inc. (OTCMKTS:CCEL) Short Interest Update
americanbankingnews.com - March 27 at 12:40 PM
Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University Other OTC:CCELCord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University Other OTC:CCEL
compsmag.com - February 27 at 9:13 AM
Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement ...Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement ...
apnews.com - February 27 at 12:41 AM
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020
finance.yahoo.com - February 24 at 6:10 PM
Cryo-cell International Inc (CCEL) Chairman, Co-CEO David Portnoy Bought $65,703 of SharesCryo-cell International Inc (CCEL) Chairman, Co-CEO David Portnoy Bought $65,703 of Shares
sports.yahoo.com - November 6 at 12:12 AM
Cryo-cell International Inc (CCEL) Chairman, Co-CEO David Portnoy Bought $77,098 of SharesCryo-cell International Inc (CCEL) Chairman, Co-CEO David Portnoy Bought $77,098 of Shares
ca.finance.yahoo.com - October 28 at 9:53 AM
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial ResultsCord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results
benzinga.com - October 15 at 7:14 PM
Insider Buys Cryo-Cell International StockInsider Buys Cryo-Cell International Stock
www.benzinga.com - July 17 at 12:34 PM
Cord Blood Banking Leader Cryo-Cell Enters into Patent Option Agreement with Duke UniversityCord Blood Banking Leader Cryo-Cell Enters into Patent Option Agreement with Duke University
finance.yahoo.com - June 11 at 8:29 PM
Cryo-Cell to Donate 50,000 Face Masks to OBGYN Practices and Patients Around the Country Amidst COVID-19Cryo-Cell to Donate 50,000 Face Masks to OBGYN Practices and Patients Around the Country Amidst COVID-19
markets.businessinsider.com - June 8 at 10:27 AM
Cryo-Cell International Inc.Cryo-Cell International Inc.
www.marketwatch.com - June 7 at 12:48 PM
Cryo-Cell International, Inc. (CCEL)Cryo-Cell International, Inc. (CCEL)
sg.finance.yahoo.com - May 25 at 10:37 PM
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2020 Financial ResultsCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2020 Financial Results
finance.yahoo.com - April 14 at 8:32 PM
Cryo-Cell Confirms Specimen Longevity of 23+ Years with Optimal CD34 ViabilityCryo-Cell Confirms Specimen Longevity of 23+ Years with Optimal CD34 Viability
markets.businessinsider.com - March 13 at 9:03 PM
SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Cryo-Cell International, Inc. And Advises Investors WithSHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Cryo-Cell International, Inc. And Advises Investors With
www.bloomberg.com - February 28 at 6:15 PM
Cryo-Cell Reports Financial Results For Fiscal Year Ended November 30, 2019Cryo-Cell Reports Financial Results For Fiscal Year Ended November 30, 2019
finance.yahoo.com - February 27 at 10:02 PM
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2019 Financial ResultsCord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2019 Financial Results
finance.yahoo.com - October 15 at 6:32 PM
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2019 Financial ResultsCord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2019 Financial Results
finance.yahoo.com - July 15 at 4:48 PM
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2019 Financial ResultsCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2019 Financial Results
finance.yahoo.com - April 15 at 5:21 PM
Cryo-Cell International IncCryo-Cell International Inc
www.bloomberg.com - March 19 at 10:47 AM
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2018Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2018
finance.yahoo.com - February 28 at 5:11 PM
DateCompanyBrokerageAction
3/9/2021Caladrius BiosciencesBrookline Capital ManagementBoost Price Target
1/19/2021Caladrius BiosciencesHC WainwrightReiterated Rating
5/18/2020Caladrius BiosciencesDawson JamesDowngrade
5/15/2020Caladrius BiosciencesChardan CapitalReiterated Rating
5/14/2019Caladrius BiosciencesWBB SecuritiesInitiated Coverage
(Data available from 4/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.